Watermark
  Back to Search Results

BGB-16673-304

Recruiting

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Request Information

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-16673-304

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT06973187

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2025

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents